C3 and interstitial lung disease: Type III collagen formation biomarkers PC3X and PRO-C3 showed significantly elevated serum levels in post-COVID ILD patients as compared to COVID-19 without ILD (p = 0.023 and p = 0.032, respectively), see Fig. 3.